GlassScriptPhysician profile
Patricia Thomas
NPI 1366754970
$10,988.15
in general payments reported to CMS, 2019-2025
6 companies · $2,772 in 2025
The $2,772 reported for 2025 was more than what 88% of Pediatric Cardiology providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $785 · 2020: $89.18 · 2021: $123 · 2022: $3,060 · 2023: $1,344 · 2024: $2,814 · 2025: $2,772.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,248 · Food and Beverage: $2,482 · Consulting Fee: $1,200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,247.71 |
| Food and Beverage | $2,482.48 |
| Consulting Fee | $1,200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $5,769.67 | 2019-2025 | Aveir, Ensite Precision, Ensite |
| Medtronic, INC. | $3,342.27 | 2022-2023 | Micra, Linq II |
| Altathera Pharmaceuticals LLC | $1,382.42 | 2024 | Sotalol Hydrochloride |
| Boston Scientific Corporation | $413.92 | 2019-2022 | |
| Bardy Diagnostics, INC. | $43.97 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $35.90 | 2021-2023 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patricia Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.